New Zealand has paused new prescriptions of puberty blockers for young people with gender dysphoria, citing a need for more evidence from a UK clinical trial, while maintaining access for existing users and affirming care pathways.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 3 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
divergent views on safety and evidence quality
New zealand pushes pause on puberty blockers pending uk trialsurgeons dispute accident causality
ACC paid for surgery, then pulled the plug: Woman faces up to $40k bill or years of painSocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.
